A recently published study in European Urology has again (partially) validated the utility of a specific type of genomic testing as a way to project risk for progressive disease in men initially diagnosed with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: genomic, GPS, Oncotype GX, outcome, risk, test | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 